Literature DB >> 7682861

Hepatitis C virus infection and mixed cryoglobulinemia: a striking association.

F Dammacco1, D Sansonno, V Cornacchiulo, C Mennuni, R Carbone, G Lauletta, A R Iacobelli, R Rizzi.   

Abstract

The high frequency of liver involvement in cryoglobulinemia is well established. Although both etiology and pathogenesis have remained so far undefined, recent studies suggest an association of mixed cryoglobulinemia with hepatitis C virus infection. To explore this hypothesis further, we assessed the prevalence of hepatitis C virus antibodies and RNA in a large group of patients, including: (1) 35 patients with cryoglobulinemia without clinical evidence of liver involvement (group 1), (2) 15 patients with symptomatic cryoglobulinemia associated with chronic liver disease (group 2) and (3) 12 patients with asymptomatic cryoglobulinemia associated with chronic liver disease (group 3). Anti-hepatitis C virus antibodies were detected by a second-generation enzyme-linked immunosorbent assay and third-generation immunoblot (SIA Prototype RIBA), whereas the polymerase chain reaction was used for the detection of viral RNA. Anti-hepatitis C virus antibodies, as detected by enzyme-linked immunosorbent assay, were demonstrated in 21 (60%) patients from group 1, 11 (73.3%) from group 2 and 10 (83.3%) from group 3. The immunoblot identified as positive 3 further patients in group 1 (giving a prevalence of 68.6%) and all patients in groups 2 and 3. Hepatitis C virus RNA was demonstrated in cryoprecipitates from 21 of 24 immunoblot-positives and from 6 of 11 immunoblot-negatives, indicating an actual active viral replication in 77.1% of group 1. This was also found in 13 (86.7%) and 10 (83.3%) cryoprecipitates of groups 2 and 3, respectively. Type II cryoglobulinemia was the prevalent form in group 1 (88.6%) and group 2 (73.3%), whereas type III was found in group 3 (58.3%) and in 26.7% of group 2.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7682861     DOI: 10.1007/bf02592281

Source DB:  PubMed          Journal:  Int J Clin Lab Res        ISSN: 0940-5437


  7 in total

Review 1.  Mixed cryoglobulinemia as a model of systemic vasculitis.

Authors:  F Dammacco; D Sansonno
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

2.  Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia.

Authors:  D Sansonno; G Lauletta; L Nisi; P Gatti; F Pesola; N Pansini; F Dammacco
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

3.  Clinical significance of serum hepatitis C virus (HCV) RNA as marker of HCV infection.

Authors:  M G Marin; S Bresciani; M Puoti; A Rodella; A Gussago; A Ravaggi; G Pizzocolo; A Albertini; E Cariani
Journal:  J Clin Microbiol       Date:  1994-12       Impact factor: 5.948

Review 4.  The cancer stem cell: evidence for its origin as an injured autoreactive T cell.

Authors:  Peter Grandics
Journal:  Mol Cancer       Date:  2006-02-14       Impact factor: 27.401

5.  Persistent Hepatitis C Virus-Associated Cryoglobulinemic Glomerulonephritis in Patients Successfully Treated With Direct-Acting Antiviral Therapy.

Authors:  Dominick Santoriello; Nanda K Pullela; Kalpana A Uday; Shawn Dhupar; Jai Radhakrishnan; Vivette D D'Agati; Glen S Markowitz
Journal:  Kidney Int Rep       Date:  2018-04-10

Review 6.  Hepatitis C virus infection and mixed cryoglobulinemia.

Authors:  Gianfranco Lauletta; Sabino Russi; Vincenza Conteduca; Loredana Sansonno
Journal:  Clin Dev Immunol       Date:  2012-07-10

7.  Enhanced activation of memory, but not naïve, B cells in chronic hepatitis C virus-infected patients with cryoglobulinemia and advanced liver fibrosis.

Authors:  Deanna M Santer; Mang M Ma; Darren Hockman; Abdolamir Landi; D Lorne J Tyrrell; Michael Houghton
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.